. 2015 Jun 1;20(10):1337–1345. doi: 10.1111/tmi.12544

Table 1.

Cost per day of drug regimens according to South African national guidelines by drug resistance category (in 2013 USD)

Drug resistance profile	Treatment regimen	Cost per day
Drug resistance profile	Treatment regimen	Intensive phase	Continuation phase
RIF‐mono	Int: Kan/Mox/Tzd/Ethio/INH Cont: Mox/Tzd/Ethio/INH	3.64	3.20
MDR‐TB	Int: Kan/Mox/Tzd/Ethio Cont: Mox/Tzd/Ethio	3.64	3.20
Pre‐XDR (FLQ)	Int: Kan/Mox/Tzd/Ethio/PAS/Clof Cont: Mox/Tzd/Ethio/PAS/Clof	9.33	8.88
Pre‐XDR (INJ)	Int: Cap/Mox/Tzd/Ethio/PAS/Clof Cont: Mox/Tzd/Ethio/PAS/Clof	18.93	8.88
XDR‐TB	Int: Cap/Mox/Tzd/Ethio/PAS/Clof Cont: Mox/Tzd/Ethio/PAS/Clof	18.93	8.88

Int, intensive phase; Cont, continuation phase; RIF‐mono, rifampicin mono‐resistance; MDR‐TB, multidrug‐resistant TB; Pre‐XDR (FLQ), MDR‐TB plus fluoroquinolone resistance; Pre‐XDR (INJ), MDR‐TB plus second‐line injectable resistance; XDR‐TB, extensively drug‐resistant TB; Kan, kanamycin; Mox, moxifloxacin; Tzd, Terizidine; Ethio, ethionamide; INH, isoniazid; PAS, para‐amino salicylic acid; Clof, clofazimine.